Food colouring additives and cancer incidence in the NutriNet-Santé prospective cohort.
코호트
2/5 보강
OpenAlex 토픽 ·
Dye analysis and toxicity
Nutritional Studies and Diet
Melamine detection and toxicity
Our study aimed to assess potential associations between food colouring additives and cancer incidence in the French NutriNet-Santé cohort.
APA
Sanam Shah, A Hasenböhler, et al. (2026). Food colouring additives and cancer incidence in the NutriNet-Santé prospective cohort.. European journal of epidemiology. https://doi.org/10.1007/s10654-026-01393-3
MLA
Sanam Shah, et al.. "Food colouring additives and cancer incidence in the NutriNet-Santé prospective cohort.." European journal of epidemiology, 2026.
PMID
41954817 ↗
Abstract 한글 요약
Our study aimed to assess potential associations between food colouring additives and cancer incidence in the French NutriNet-Santé cohort. A total of 105,260 adults (78.3% females; mean age 42.0 ± 14.5y) without prevalent cancer and who completed ≥ 2 24-hour dietary records at baseline were followed for > 7 years. Dietary intakes were assessed using repeated brand-specific 24 h records, and cumulative time-dependent exposure to food additives was evaluated through multiple composition databases and ad-hoc laboratory assays in food matrices. Associations between exposures to food colouring additives (sex-specific tertiles if proportion of exposed participants > 2/3, or non-exposed/lower/higher exposed based on sex-specific median otherwise) and cancer incidence were assessed using multivariable Cox models. We identified 4,226 incident cancer cases (508 prostate, 1,208 breast [387 premenopausal and 821 postmenopausal], and 352 colorectal). Total food colouring additives were associated with higher overall [HR (95%CI): 1.14 (1.05-1.24); absolute risk at age 60: 13.3% (higher consumers) vs. 12.1% (lower/non-consumers)], breast [1.21 (1.03-1.42); 5.7%, 4.8%], and postmenopausal breast [1.32 (1.09-1.61); 14.9%, 12.5%] cancer incidence. After False Discovery Rate correction, only plain caramel (European code: E150a) was associated with overall cancer [1.15 (1.07-1.25); 14.0%, 12.1%] and beta-carotene (E160a) with overall [1.16 (1.07-1.25); 13.7%, 11.9%] and breast cancer [1.41 (1.23-1.62); 6.2%, 4.4%]. This study provides novel exploratory evidence linking colouring additives to cancer incidence. Further research is needed to elucidate underlying mechanisms. Findings support recommendations to limit exposure to non-essential food additives (i.e. used primarily for sensory or aesthetic purposes rather than for food safety or preservation) and inform regulatory reassessment.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Breast Cancer After Breast Augmentation study (BCABA): A national multicentre collaborative study of patient management and outcomes.
- IRS2 as a driver and therapeutic target in brain metastases from colorectal cancer: a systematic review of mechanistic and translational evidence.
- Timing and Resolution of Bothersome Hot Flashes Following Short Course Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix, and Stereotactic Body Radiotherapy for Localized Prostate Cancer.
- Atypical Migrating Nummular Retinal Lesions in an Immunosuppressed Patient With Whipple Disease.
- Impact of chronotherapy and time-of-day on surgical and adjuvant outcomes in glioblastoma and mixed high-grade glioma patients: a systematic review.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.